![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 405/12 | (2006.01) |
C07D 405/12 | (2013.01) | ||
C08G 65/331 | (2006.01) | ||
A61K 38/07 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 19/08 | (2018.01) | ||
A61K 38/07 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61K 47/10 | (2017.01) | ||
C07K 5/10 | (2006.01) | ||
C07K 5/117 | (2006.01) |
(11) | Patento numeris | 3464277 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17730293.2 |
Europos patento paraiškos padavimo data | 2017-05-23 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-04-10 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-28 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2017/034029 |
Data | 2017-05-23 |
(87) | Numeris | WO 2017/205392 |
Data | 2017-11-30 |
(30) | Numeris | Data | Šalis |
201662340926 P | 2016-05-24 | US | |
201762485812 P | 2017-04-14 | US |
(72) |
LUEHR, Gary , US
ANIK, Shabbir T. , US
PENG, Ge , US
DOTSENKO, Irina , US
PHIASIVONGSA, Pasit , US
ROMANINI, Dante , US
|
(73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
|
(54) | PEGYLATED CARFILZOMIB COMPOUNDS |
PEGYLATED CARFILZOMIB COMPOUNDS |